SOLAND DANIEL B 1318485 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Soland Daniel B | DIRECTOR | acq | 18002.0 | 64.29 | 1.11 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 28002.0 | 162.63 (ACAD) |
2023-08-03 | 2023-08-01 | 2023-08-01 | 4 | Soland Daniel B | DIRECTOR | acq | 15000.0 | 75.0 | 1.56 | 1.62 | Direct | Ordinary Shares | DBV TECHNOLOGIES S.A. | code P | 20000.0 | 96.25 (DBVT) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Soland Daniel B | DIRECTOR | acq | 6652.0 | 100.0 | 0.41 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 6652.0 | 162.63 (ACAD) |
2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Soland Daniel B | DIRECTOR | dsp | 18002.0 | 100.0 | 1.11 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0 | 162.63 (ACAD) |
2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Soland Daniel B | DIRECTOR | acq | 11045.0 | 100.0 | 0.68 | 23.9 | Direct | Director Stock Options (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 11045.0 | 162.63 (ACAD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)